OTHER GROUP COMPANIES
market

Strides Pharma Science reports consolidated net loss of Rs 135.89 crore in the June 2022 quarter

Sales rise 36.56% to Rs 940.07 crore

July 29, 2022 1:48 IST | capital market
Net Loss of Strides Pharma Science reported to Rs 135.89 crore in the quarter ended June 2022 as against net loss of Rs 205.20 crore during the previous quarter ended June 2021. Sales rose 36.56% to Rs 940.07 crore in the quarter ended June 2022 as against Rs 688.37 crore during the previous quarter ended June 2021.
ParticularsQuarter Ended
?Jun. 2022Jun. 2021% Var.
Sales940.07688.37 37
OPM %0.40-10.13 -
PBDT-37.23-97.69 62
PBT-97.63-152.57 36
NP-135.89-205.20 34
Powered by Capital Market - Live News

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000

FEATURED ARTICLE

BLOGS

Open Demat Account
  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity